USD 811.81
Price
-7.05
(-0.86%)
Day Change
|
|
---|
LLY, the overall quality is not quite good (Quality = 54) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Acceleration of net profit margin growth rate is below our criteria
In details, quality factors are not quite good , financial health is not good , and ability to make profit is good , ...
Quality Factors |
|
55% |
Timing Factors |
|
42% |
Financial Health |
|
37% |
Ability to Make Profit |
|
72% |
Return to Investors |
|
12% |
Registration Details |
Analyze Date | 2024-11-13 19:33:23 |
Symbol | LLY |
Name | ELI LILLY AND COMPANY |
Sector | Healthcare >> Drug Manufacturers - General |
Market | NYSE |
Listed Shares | 949.32 M |
Par Value | N/A |
Calculated From | Quarter |
Sign | N/A |
Market Cap (M.USD) / Sector Average | 777,356.84 / 225,845.78 |
News, Concensus, ... |
Estimation Consensus | See at WSJ.com |
Full details | See at WSJ.com |
Chart | See in Chart feature |
News | See at Yahoo Finance |